GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thalys Medical Technology Group Inc (SHSE:603716) » Definitions » Gross-Profit-to-Asset %

Thalys Medical Technology Group (SHSE:603716) Gross-Profit-to-Asset % : 13.25% (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Thalys Medical Technology Group Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Thalys Medical Technology Group's annualized Gross Profit for the quarter that ended in Mar. 2024 was ¥440 Mil. Thalys Medical Technology Group's average Total Assets over the quarter that ended in Mar. 2024 was ¥3,324 Mil. Therefore, Thalys Medical Technology Group's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 13.25%.


Thalys Medical Technology Group Gross-Profit-to-Asset % Historical Data

The historical data trend for Thalys Medical Technology Group's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thalys Medical Technology Group Gross-Profit-to-Asset % Chart

Thalys Medical Technology Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.62 14.16 13.29 11.11 10.76

Thalys Medical Technology Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.30 13.34 9.78 8.76 13.25

Competitive Comparison of Thalys Medical Technology Group's Gross-Profit-to-Asset %

For the Diagnostics & Research subindustry, Thalys Medical Technology Group's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thalys Medical Technology Group's Gross-Profit-to-Asset % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thalys Medical Technology Group's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Thalys Medical Technology Group's Gross-Profit-to-Asset % falls into.



Thalys Medical Technology Group Gross-Profit-to-Asset % Calculation

Thalys Medical Technology Group's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=392.692/( (3958.813+3341.784)/ 2 )
=392.692/3650.2985
=10.76 %

Thalys Medical Technology Group's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=440.436/( (3341.784+3306.186)/ 2 )
=440.436/3323.985
=13.25 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Thalys Medical Technology Group Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Thalys Medical Technology Group's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Thalys Medical Technology Group (SHSE:603716) Business Description

Traded in Other Exchanges
N/A
Address
1310 Jinshan Avenue, Dongxihu District, Hubei Province, Wuhan, CHN, 430040
Thalys Medical Technology Inc is an early-stage medical intensive service provider. The company specializes in intensive marketing services for medical testing, agents for in vitro diagnostic products, and research and development, production and sales of autonomous in vitro diagnostic products. The majority of the revenue is earned from its in-service medical inspection intensive marketing and services.

Thalys Medical Technology Group (SHSE:603716) Headlines

No Headlines